Biotech targeting growth factor inhibition for spinal muscular atrophy.
Industry: Health Care
First Day Return: +10.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/27/2018 |
Offer Price | $14.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 5.4 |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/23/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2012 |
Employees at IPO | 50 |
Website www.scholarrock.com |